CVE:PRO Pershimex Resources (PRO) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free PRO Stock Alerts C$0.03 -0.01 (-14.29%) (As of 05/8/2023) Add Compare Share Share Today's RangeC$0.03▼C$0.0350-Day RangeC$0.03▼C$0.0352-Week RangeC$0.02▼C$0.04Volume15,195 shsAverage Volume171,615 shsMarket CapitalizationC$4.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesInsider TradesStock AnalysisHeadlinesInsider Trades Get Pershimex Resources alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Pershimex Resources Stock (CVE:PRO)Pershimex Resources Corporation engages in the exploration and evaluation of mineral resources in Canada. The company holds 100% interests in the the Villebon property that include 43 claims covering an area of approximately 18 square kilometers located in the Villebon Township, Abitibi; the Forsan property comprising 27 claims covering an area of approximately 8 square kilometers; and the Courville property that consists of 312 claims covering an area of approximately 151.82 square kilometers located in the Carpentier and Courville townships. It also holds 49% interests in the Malartic property, which comprise 6 blocks of contiguous claims covering an area of approximately 36 square kilometers located near the prolific Cadillac Fault. The company was formerly known as Khalkos Exploration Inc. Pershimex Resources Corporation was incorporated in 2007 and is headquartered in Val-d'Or, Canada.Read More PRO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRO Stock News HeadlinesApril 13, 2024 | americanbankingnews.comPershimex Resources (CVE:PRO) Stock Crosses Above 200-Day Moving Average of $0.03April 4, 2024 | yahoo.comDrug use resource hub opens in north Minneapolis after state legalizes safe injection sitesApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.March 19, 2024 | cnet.comBest AirPods Pro Accessories for 2024March 15, 2024 | macrumors.comAirPods ProMarch 13, 2024 | msn.comOrganize Your Projects With Microsoft Project Pro for Only $29.99February 24, 2024 | macrumors.comApple's 2024 OLED iPad Pro: All the Rumors So FarJanuary 30, 2024 | macrumors.comBest MacBook Pro and MacBook Air Deals for January 2024April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 17, 2024 | realmoney.thestreet.comParex Resources price target lowered by C$4.75 at StifelJanuary 17, 2024 | realmoney.thestreet.comParex Resources price target lowered by C$1 at RBC CapitalDecember 28, 2023 | nypost.comBurn stubborn fat without having to hit the gym with the new and improved Fat Iron Pro!December 12, 2023 | seekingalpha.comParex Resources: Attractive, But I'm Hoping For A Bigger PullbackDecember 9, 2023 | macrumors.com13-Inch MacBook ProDecember 6, 2023 | yahoo.comIPMX Provides a Framework for Pro AVNovember 15, 2023 | tmcnet.comQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationOctober 21, 2023 | cnet.comBest iPhone 15 and iPhone 15 Pro Cases for 2023October 1, 2023 | bbc.co.ukPro-euthanasia argumentsAugust 20, 2023 | appleinsider.comBest MacBook Pro DealsJuly 15, 2023 | macrumors.comiPhone 15 ProMay 12, 2023 | finanznachrichten.deAbcourt Mines Inc.: Abcourt Completes Acquisition of Pershimex by MergerMay 11, 2023 | finance.yahoo.comAbcourt Completes Acquisition of Pershimex by MergerApril 25, 2023 | macrumors.com14- and 16-Inch MacBook ProApril 25, 2023 | theglobeandmail.comClosing Bell: Pershimex Resources Corp flat on Monday (PRO)April 19, 2023 | theglobeandmail.comClosing Bell: Pershimex Resources Corp up on Tuesday (PRO)April 13, 2023 | theglobeandmail.comClosing Bell: Pershimex Resources Corp up on Wednesday (PRO)April 11, 2023 | theglobeandmail.comClosing Bell: Pershimex Resources Corp down on Monday (PRO)See More Headlines Receive PRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pershimex Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorBasic Materials Industry Industrial Metals & Minerals Sub-IndustryN/A Current SymbolCVE:PRO CUSIPN/A CIKN/A Webwww.khalkos.com Phone+1-514-7509026FaxN/AEmployees1,403Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on Equity1.11% Return on Assets3.00% Debt Debt-to-Equity RatioN/A Current Ratio0.76 Quick Ratio40.31 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow10.00 Book ValueC$0.06 per share Price / Book0.50Miscellaneous Outstanding Shares138,820,000Free FloatN/AMarket CapC$4.16 million OptionableNot Optionable Beta1.12 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Robert Gagnon B.Sc.P. Geo., P.Geo., Pres, CEO & DirectorMr. Jacques Levesque FCA (Age 76)Chief Financial Officer Comp: $60kMr. Jacques Brunelle (Age 61)VP of Corp. Devel. Comp: $2kMr. Serge Marc Racine (Age 58)Independent Director & Sec. Key CompetitorsScottie ResourcesCVE:ROTStone Gold Inc. (CIT.V)CVE:CITAlgold Resources Ltd. (ALG.V)CVE:ALGXiana MiningCVE:XIABlende Silver Corp. (BCK.V)CVE:BCKView All Competitors PRO Stock Analysis - Frequently Asked Questions How have PRO shares performed in 2024? Pershimex Resources' stock was trading at C$0.03 at the beginning of the year. Since then, PRO shares have increased by 0.0% and is now trading at C$0.03. View the best growth stocks for 2024 here. What other stocks do shareholders of Pershimex Resources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pershimex Resources investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL). How do I buy shares of Pershimex Resources? Shares of PRO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:PRO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pershimex Resources Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.